Review Series on a Quarter Century of TKIs in CML
This Blood Podcast episode reviews the impact of TKIs on CML treatment over the past 25 years. Contributing authors Drs. Brian Drucker, Francois Guillot, Tim Hughes, and Michael Deininger discuss the changes since the introduction of tyrosine kinase inhibitors.